CTOs on the Move


 
Dataray is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.datarayusa.com
  • 1141 SE Grand Blvd Ste 105
    Oklahoma City, OK USA 73129
  • Phone: 800.477.5317

Executives

Name Title Contact Details

Similar Companies

Dedham Medical Assoc

Dedham Medical Assoc is a Dedham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AVANCA Medical Devices

AVANCA Medical Devices is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Impedimed

ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed`s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm in female breast cancer patients.

MedicaMetrix

We are a startup up medical device company whose sole focus and mission are to transform patient care through innovative Med-tech solutions. Our initial product is a minimally invasive Prostate Volume Measurement Device to help doctors evaluate a patient`s prostate health. Our solution includes a controller that receives measurement data from an encoder device. The encoder a disposable, single-use component made with an injection molding process. We are in the proof of concept phase and want to move to test marketing trials and production by end of 2020.